Form 4 Tracker
Christopher Causey

Director · 3 filings · Latest: Mar 30, 2026

UNITED THERAPEUTICS Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
UTHR
Christopher CauseyDirectorMar 30, 2026
Sale
$604.641,300$786.0K4,190
UTHR
Christopher CauseyDirectorMar 30, 2026
Option Exercise
$119.761,300$155.7K5,490
UTHR
CHRISTOPHER CAUSEYMar 30, 2026
Proposed Sale
$604.641,300$786.0K
UTHR
Christopher CauseyDirectorMar 4, 2026
Sale
$490.1720$9.8K4,190
UTHR
Christopher CauseyDirectorMar 4, 2026
Option Exercise
$119.7620$2.4K4,210
UTHR
CHRISTOPHER CAUSEYMar 4, 2026
Proposed Sale
$490.1720$9.8K
UTHR
CHRISTOPHER CAUSEYFeb 25, 2026
Proposed Sale
$520.001,000$520.0K
UTHR
Christopher CauseyDirectorFeb 25, 2026
Sale
$520.001,000$520.0K4,190
UTHR
Christopher CauseyDirectorFeb 25, 2026
Option Exercise
$119.761,000$119.8K5,190
UTHR
CHRISTOPHER CAUSEYJan 6, 2026
Proposed Sale
$510.001,000$510.0K
UTHR
CHRISTOPHER CAUSEYJan 2, 2026
Proposed Sale
$500.011,000$500.0K
UTHR
CHRISTOPHER CAUSEYSep 24, 2025
Proposed Sale
$440.001,000$440.0K
UTHR
CHRISTOPHER CAUSEYSep 2, 2025
Proposed Sale
$423.213,000$1.3M
UTHR
CHRISTOPHER CAUSEYNov 1, 2024
Proposed Sale
$376.63510$192.1K
UTHR
CHRISTOPHER CAUSEYAug 21, 2024
Proposed Sale
$349.001,210$422.3K